SIMILAR PATTERNS OF AMINO ACIDS FOR 3LN1_B_CELB682_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1cb8 PROTEIN
(CHONDROITINASE AC)

(Pedobacter
heparinus) 		PF02278
(Lyase_8)
PF02884
(Lyase_8_C)
PF08124
(Lyase_8_N) 		4 LEU A 383
SER A 384
LEU A 296
ILE A 409
 None
 0.91A 3ln1B-1cb8A:
0.0		 3ln1B-1cb8A:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e8c UDP-N-ACETYLMURAMOYL
ALANYL-D-GLUTAMATE--
2,6-DIAMINOPIMELATE
LIGASE

(Escherichia
coli) 		PF01225
(Mur_ligase)
PF02875
(Mur_ligase_C)
PF08245
(Mur_ligase_M) 		4 LEU A 312
SER A 309
LEU A 328
ILE A 287
 None
 0.94A 3ln1B-1e8cA:
0.0		 3ln1B-1e8cA:
19.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ebv PROSTAGLANDIN H2
SYNTHASE

(Ovis aries) 		PF00008
(EGF)
PF03098
(An_peroxidase) 		5 ARG A 120
LEU A 352
SER A 353
LEU A 384
ILE A 517
 SCL  A 700 (-3.9A)
SCL  A 700 ( 4.8A)
None
None
None
 0.50A 3ln1B-1ebvA:
58.3		 3ln1B-1ebvA:
64.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ebv PROSTAGLANDIN H2
SYNTHASE

(Ovis aries) 		PF00008
(EGF)
PF03098
(An_peroxidase) 		5 LEU A 352
SER A 353
LEU A 384
ILE A 517
PHE A 518
 SCL  A 700 ( 4.8A)
None
None
None
None
 0.82A 3ln1B-1ebvA:
58.3		 3ln1B-1ebvA:
64.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ebv PROSTAGLANDIN H2
SYNTHASE

(Ovis aries) 		PF00008
(EGF)
PF03098
(An_peroxidase) 		5 LEU A 352
SER A 353
LEU A 507
ILE A 517
PHE A 518
 SCL  A 700 ( 4.8A)
None
None
None
None
 1.14A 3ln1B-1ebvA:
58.3		 3ln1B-1ebvA:
64.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ej6 LAMBDA1

(Reovirus sp.) 		no annotation 4 ARG B1207
LEU B1247
LEU B1253
ILE B1245
 None
 0.95A 3ln1B-1ej6B:
0.0		 3ln1B-1ej6B:
18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h6u INTERNALIN H

(Listeria
monocytogenes) 		PF08191
(LRR_adjacent)
PF12354
(Internalin_N)
PF12799
(LRR_4)
PF13516
(LRR_6) 		4 LEU A 163
SER A 164
LEU A 171
ILE A 144
 None
 0.89A 3ln1B-1h6uA:
undetectable		 3ln1B-1h6uA:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h8c FAS-ASSOCIATED
FACTOR 1

(Homo sapiens) 		PF00789
(UBX) 		4 LEU A  65
SER A  64
LEU A  76
ILE A  30
 None
 0.88A 3ln1B-1h8cA:
0.0		 3ln1B-1h8cA:
12.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j1w ISOCITRATE
DEHYDROGENASE

(Azotobacter
vinelandii) 		PF03971
(IDH) 		4 LEU A 740
LEU A 629
ILE A 687
PHE A 684
 None
 0.88A 3ln1B-1j1wA:
0.0		 3ln1B-1j1wA:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jmk SURFACTIN SYNTHETASE

(Bacillus
subtilis) 		PF00975
(Thioesterase) 		4 LEU C  41
SER C  38
LEU C 175
ILE C  21
 None
 0.89A 3ln1B-1jmkC:
0.0		 3ln1B-1jmkC:
16.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1js6 DOPA DECARBOXYLASE

(Sus scrofa) 		PF00282
(Pyridoxal_deC) 		4 LEU A  94
LEU A 114
ARG A 356
ILE A  98
 None
 0.94A 3ln1B-1js6A:
0.0		 3ln1B-1js6A:
21.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jsw L-ASPARTATE
AMMONIA-LYASE

(Escherichia
coli) 		PF00206
(Lyase_1)
PF10415
(FumaraseC_C) 		4 LEU A 386
LEU A 210
ILE A 391
PHE A 174
 None
 0.90A 3ln1B-1jswA:
undetectable		 3ln1B-1jswA:
21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mn3 VACUOLAR PROTEIN
SORTING-ASSOCIATED
PROTEIN VPS9

(Saccharomyces
cerevisiae) 		PF02845
(CUE) 		4 LEU A 400
SER A 399
LEU A 447
ILE A 404
 None
 0.89A 3ln1B-1mn3A:
undetectable		 3ln1B-1mn3A:
6.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mu2 HIV-2 RT

(Human
immunodeficiency
virus 2) 		PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb) 		4 LEU B 310
SER B 311
LEU B 260
ILE B 244
 None
 0.83A 3ln1B-1mu2B:
undetectable		 3ln1B-1mu2B:
21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1n8y PROTOONCOPROTEIN

(Rattus
norvegicus) 		PF00757
(Furin-like)
PF01030
(Recep_L_domain)
PF14843
(GF_recep_IV) 		5 LEU C 353
SER C 352
LEU C 401
ILE C 335
PHE C 355
 None
 1.30A 3ln1B-1n8yC:
undetectable		 3ln1B-1n8yC:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nnw HYPOTHETICAL PROTEIN

(Pyrococcus
furiosus) 		no annotation 4 LEU A 209
LEU A  21
ILE A 220
PHE A 207
 None
 0.87A 3ln1B-1nnwA:
undetectable		 3ln1B-1nnwA:
18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nz8 TRANSCRIPTION
ANTITERMINATION
PROTEIN NUSG

(Thermus
thermophilus) 		PF02357
(NusG) 		4 LEU A 104
SER A 105
ARG A 110
ILE A 112
 None
 0.77A 3ln1B-1nz8A:
undetectable		 3ln1B-1nz8A:
17.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1oe5 SINGLE-STRAND
SELECTIVE
MONOFUNCTIONAL
URACIL DNA
GLYCOSYLASE

(Xenopus laevis) 		no annotation 4 LEU A  53
SER A  54
LEU A 193
ILE A 204
 None
EPE  A1285 (-4.5A)
None
None
 0.91A 3ln1B-1oe5A:
undetectable		 3ln1B-1oe5A:
18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1or4 HEME-BASED
AEROTACTIC
TRANSDUCER HEMAT

(Bacillus
subtilis) 		PF11563
(Protoglobin) 		4 ARG A  24
LEU A  54
ILE A  58
PHE A 104
 None
 0.93A 3ln1B-1or4A:
undetectable		 3ln1B-1or4A:
14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1p2z HEXON PROTEIN

(Human
mastadenovirus
C) 		PF01065
(Adeno_hexon)
PF03678
(Adeno_hexon_C) 		4 LEU A 347
ARG A 561
ILE A 575
PHE A 340
 None
 0.90A 3ln1B-1p2zA:
undetectable		 3ln1B-1p2zA:
19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pii N-(5'PHOSPHORIBOSYL)
ANTHRANILATE
ISOMERASE

(Escherichia
coli) 		PF00218
(IGPS)
PF00697
(PRAI) 		4 LEU A 188
LEU A 135
ILE A   8
PHE A 116
 None
 0.84A 3ln1B-1piiA:
undetectable		 3ln1B-1piiA:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q1o CELL DIVISION
CONTROL PROTEIN 24

(Saccharomyces
cerevisiae) 		PF00564
(PB1) 		4 LEU A 853
SER A 767
LEU A 794
ILE A 802
 None
 0.90A 3ln1B-1q1oA:
undetectable		 3ln1B-1q1oA:
9.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qh4 CREATINE KINASE

(Gallus gallus) 		PF00217
(ATP-gua_Ptrans)
PF02807
(ATP-gua_PtransN) 		4 ARG A 130
LEU A 121
LEU A 317
ILE A 361
 None
 0.94A 3ln1B-1qh4A:
undetectable		 3ln1B-1qh4A:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r3d CONSERVED
HYPOTHETICAL PROTEIN
VC1974

(Vibrio cholerae) 		PF12697
(Abhydrolase_6) 		4 LEU A 152
SER A 153
LEU A 188
ILE A 148
 None
 0.95A 3ln1B-1r3dA:
undetectable		 3ln1B-1r3dA:
19.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1t6p PHENYLALANINE
AMMONIA-LYASE

(Rhodotorula
toruloides) 		PF00221
(Lyase_aromatic) 		5 LEU A 636
SER A 635
LEU A 585
ARG A 641
PHE A 544
 None
 1.44A 3ln1B-1t6pA:
0.0		 3ln1B-1t6pA:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ttx ONCOMODULIN

(Homo sapiens) 		PF13499
(EF-hand_7) 		4 LEU A  64
LEU A  36
ILE A  98
PHE A 103
 None
 0.84A 3ln1B-1ttxA:
undetectable		 3ln1B-1ttxA:
12.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u6g TIP120 PROTEIN

(Homo sapiens) 		PF08623
(TIP120) 		4 LEU C 214
LEU C 162
ARG C 244
ILE C 237
 None
 0.94A 3ln1B-1u6gC:
undetectable		 3ln1B-1u6gC:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ua2 CELL DIVISION
PROTEIN KINASE 7

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A 257
LEU A 203
ILE A 260
PHE A 261
 None
 0.95A 3ln1B-1ua2A:
undetectable		 3ln1B-1ua2A:
20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uf2 CORE PROTEIN P3

(Rice dwarf
virus) 		PF09231
(RDV-p3) 		4 LEU A 686
SER A 683
ILE A 693
PHE A 694
 None
 0.90A 3ln1B-1uf2A:
0.0		 3ln1B-1uf2A:
19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vma CELL DIVISION
PROTEIN FTSY

(Thermotoga
maritima) 		PF00448
(SRP54)
PF02881
(SRP54_N) 		5 LEU A  71
SER A  70
LEU A  79
ARG A  59
ILE A  56
 None
 1.36A 3ln1B-1vmaA:
undetectable		 3ln1B-1vmaA:
19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vma CELL DIVISION
PROTEIN FTSY

(Thermotoga
maritima) 		PF00448
(SRP54)
PF02881
(SRP54_N) 		4 LEU A  79
LEU A   7
ILE A 267
PHE A 282
 None
 0.91A 3ln1B-1vmaA:
undetectable		 3ln1B-1vmaA:
19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x8v CYTOCHROME P450 51

(Mycobacterium
tuberculosis) 		PF00067
(p450) 		5 SER A 148
LEU A 204
ARG A 158
ILE A 153
PHE A 157
 None
 1.34A 3ln1B-1x8vA:
0.5		 3ln1B-1x8vA:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xec DECORIN

(Bos taurus) 		PF01462
(LRRNT)
PF13855
(LRR_8) 		4 LEU A 223
SER A 224
LEU A 236
ILE A 228
 None
 0.94A 3ln1B-1xecA:
undetectable		 3ln1B-1xecA:
19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1z5z HELICASE OF THE
SNF2/RAD54 FAMILY

(Sulfolobus
solfataricus) 		PF00271
(Helicase_C) 		4 LEU A 895
SER A 891
LEU A 704
ILE A 691
 None
 0.87A 3ln1B-1z5zA:
undetectable		 3ln1B-1z5zA:
17.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zbu 3'-5' EXONUCLEASE
ERI1

(Homo sapiens) 		PF00929
(RNase_T) 		4 ARG A 348
LEU A 239
ILE A 151
PHE A 203
 None
 0.76A 3ln1B-1zbuA:
undetectable		 3ln1B-1zbuA:
20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b9b FUSION GLYCOPROTEIN
F0

(Mammalian
rubulavirus 5) 		PF00523
(Fusion_gly) 		4 LEU A 203
LEU A 262
ILE A 206
PHE A 207
 None
 0.82A 3ln1B-2b9bA:
undetectable		 3ln1B-2b9bA:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bwj ADENYLATE KINASE 5

(Homo sapiens) 		PF00406
(ADK) 		4 ARG A 100
LEU A  79
ILE A 112
PHE A 108
 None
 0.93A 3ln1B-2bwjA:
undetectable		 3ln1B-2bwjA:
16.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c1l RESTRICTION
ENDONUCLEASE

(Bacillus firmus) 		PF13091
(PLDc_2) 		4 ARG A 341
LEU A 205
LEU A 201
ILE A 316
 None
 0.69A 3ln1B-2c1lA:
undetectable		 3ln1B-2c1lA:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2d0j GALACTOSYLGALACTOSYL
XYLOSYLPROTEIN
3-BETA-GLUCURONOSYLT
RANSFERASE 2

(Homo sapiens) 		PF03360
(Glyco_transf_43) 		4 LEU A 181
LEU A 277
ILE A  85
PHE A 183
 None
 0.95A 3ln1B-2d0jA:
undetectable		 3ln1B-2d0jA:
18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ewy BETA-SECRETASE 2

(Homo sapiens) 		PF00026
(Asp) 		5 LEU A 156
SER A 155
LEU A 187
ARG A 359
ILE A 162
 None
 1.22A 3ln1B-2ewyA:
undetectable		 3ln1B-2ewyA:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fa0 HMG-COA SYNTHASE

(Brassica juncea) 		PF01154
(HMG_CoA_synt_N)
PF08540
(HMG_CoA_synt_C) 		4 LEU A  64
SER A  63
LEU A  78
ILE A  70
 None
 0.90A 3ln1B-2fa0A:
undetectable		 3ln1B-2fa0A:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fzf HYPOTHETICAL PROTEIN

(Pyrococcus
furiosus) 		PF02915
(Rubrerythrin) 		4 ARG A  36
LEU A  42
SER A  41
ILE A  46
 None
 0.83A 3ln1B-2fzfA:
undetectable		 3ln1B-2fzfA:
14.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ghw ANTI-SARS SCFV
ANTIBODY, 80R

(Homo sapiens) 		PF07686
(V-set) 		4 LEU B 179
LEU B 210
ILE B 190
PHE B 194
 None
 0.88A 3ln1B-2ghwB:
undetectable		 3ln1B-2ghwB:
14.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gju 252AA LONG
HYPOTHETICAL PROTEIN

(Pyrococcus
horikoshii) 		no annotation 4 LEU A 209
LEU A  21
ILE A 220
PHE A 207
 None
 0.92A 3ln1B-2gjuA:
undetectable		 3ln1B-2gjuA:
16.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h3l LAP2 PROTEIN

(Homo sapiens) 		PF00595
(PDZ) 		4 LEU A1394
SER A1393
LEU A1404
PHE A1398
 None
 0.81A 3ln1B-2h3lA:
undetectable		 3ln1B-2h3lA:
14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hi4 CYTOCHROME P450 1A2

(Homo sapiens) 		PF00067
(p450) 		4 LEU A 497
SER A 231
LEU A 450
ILE A 386
 BHF  A 800 (-4.4A)
None
HEM  A 900 (-4.0A)
HEM  A 900 (-4.0A)
 0.67A 3ln1B-2hi4A:
0.0		 3ln1B-2hi4A:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2i7h NITROREDUCTASE-LIKE
FAMILY PROTEIN

(Bacillus cereus) 		PF00881
(Nitroreductase) 		4 ARG A  75
LEU A  62
ILE A 148
PHE A 144
 None
 0.93A 3ln1B-2i7hA:
undetectable		 3ln1B-2i7hA:
14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ik8 GUANINE
NUCLEOTIDE-BINDING
PROTEIN G(I),
ALPHA-1 SUBUNIT

(Homo sapiens) 		PF00503
(G-alpha) 		4 LEU A 283
LEU A 268
ILE A 278
PHE A 274
 None
 0.90A 3ln1B-2ik8A:
undetectable		 3ln1B-2ik8A:
19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2kr5 AFLATOXIN
BIOSYNTHESIS
POLYKETIDE SYNTHASE

(Aspergillus
parasiticus) 		PF00550
(PP-binding) 		5 LEU A  68
SER A  67
ARG A  55
ILE A  50
PHE A  54
 None
 1.47A 3ln1B-2kr5A:
undetectable		 3ln1B-2kr5A:
9.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2mbg RALA-BINDING PROTEIN
1

(Homo sapiens) 		PF00620
(RhoGAP) 		5 LEU A 267
LEU A 278
ARG A 214
ILE A 217
PHE A 213
 None
 1.48A 3ln1B-2mbgA:
undetectable		 3ln1B-2mbgA:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2mqa MINOR AMPULLATE
FIBROIN 1

(Nephila
antipodiana) 		PF12042
(RP1-2) 		4 LEU A  29
SER A  30
LEU A  83
ILE A  38
 None
 0.89A 3ln1B-2mqaA:
undetectable		 3ln1B-2mqaA:
13.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2mvu ACTINORHODIN
POLYKETIDE SYNTHASE
ACYL CARRIER PROTEIN

(Streptomyces
coelicolor) 		PF00550
(PP-binding) 		4 LEU A  26
SER A  27
LEU A  75
ILE A  38
 None
 0.93A 3ln1B-2mvuA:
undetectable		 3ln1B-2mvuA:
10.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nyt PROBABLE
C->U-EDITING ENZYME
APOBEC-2

(Homo sapiens) 		PF08210
(APOBEC_N) 		4 LEU A 139
SER A 140
LEU A 108
ILE A 135
 None
 0.93A 3ln1B-2nytA:
undetectable		 3ln1B-2nytA:
15.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nz9 BOTULINUM NEUROTOXIN
TYPE A

(Clostridium
botulinum) 		PF01742
(Peptidase_M27)
PF07951
(Toxin_R_bind_C)
PF07952
(Toxin_trans)
PF07953
(Toxin_R_bind_N) 		4 LEU A 891
SER A 892
LEU A 656
ILE A 889
 None
 0.94A 3ln1B-2nz9A:
undetectable		 3ln1B-2nz9A:
17.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o3i HYPOTHETICAL PROTEIN

(Chromobacterium
violaceum) 		PF06032
(DUF917) 		5 LEU A 364
SER A 365
LEU A 302
ILE A 369
PHE A 373
 None
 1.35A 3ln1B-2o3iA:
undetectable		 3ln1B-2o3iA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o78 PUTATIVE HISTIDINE
AMMONIA-LYASE

(Rhodobacter
sphaeroides) 		PF00221
(Lyase_aromatic) 		4 ARG A  31
LEU A  34
LEU A 108
ILE A 126
 None
 0.76A 3ln1B-2o78A:
undetectable		 3ln1B-2o78A:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2obe HEXON

(Human
mastadenovirus
E) 		PF01065
(Adeno_hexon)
PF03678
(Adeno_hexon_C) 		4 LEU A 317
ARG A 526
ILE A 540
PHE A 310
 None
 0.91A 3ln1B-2obeA:
undetectable		 3ln1B-2obeA:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2odt INOSITOL-TETRAKISPHO
SPHATE 1-KINASE

(Homo sapiens) 		PF05770
(Ins134_P3_kin) 		4 LEU X  43
SER X  44
LEU X  97
ILE X  47
 None
 0.92A 3ln1B-2odtX:
undetectable		 3ln1B-2odtX:
21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ogp PARTITIONING-DEFECTI
VE 3 HOMOLOG

(Rattus
norvegicus) 		PF00595
(PDZ) 		5 ARG A 109
LEU A  74
LEU A  27
ILE A  38
PHE A  36
 None
 1.44A 3ln1B-2ogpA:
undetectable		 3ln1B-2ogpA:
11.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2otm HYPOTHETICAL PROTEIN

(Shewanella
oneidensis) 		PF14588
(YjgF_endoribonc) 		4 LEU A  86
LEU A 118
ILE A  89
PHE A 123
 None
 0.81A 3ln1B-2otmA:
undetectable		 3ln1B-2otmA:
16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2owz FRUCTOSE-1,6-BISPHOS
PHATASE

(Escherichia
coli) 		PF00316
(FBPase) 		4 ARG A  80
LEU A  73
LEU A 167
ILE A  36
 None
 0.94A 3ln1B-2owzA:
undetectable		 3ln1B-2owzA:
19.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pg6 CYTOCHROME P450 2A6

(Homo sapiens) 		PF00067
(p450) 		4 ARG A  76
LEU A 370
ILE A 366
PHE A 480
 None
HEM  A 500 ( 3.8A)
HEM  A 500 ( 4.1A)
None
 0.91A 3ln1B-2pg6A:
0.2		 3ln1B-2pg6A:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pt5 SHIKIMATE KINASE

(Aquifex
aeolicus) 		PF01202
(SKI) 		4 ARG A  22
SER A  14
LEU A 158
ILE A  99
 None
 0.91A 3ln1B-2pt5A:
undetectable		 3ln1B-2pt5A:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pyj DNA POLYMERASE

(Bacillus virus
phi29) 		PF03175
(DNA_pol_B_2) 		4 LEU A  44
SER A  43
LEU A  58
PHE A  13
 None
 0.93A 3ln1B-2pyjA:
0.0		 3ln1B-2pyjA:
23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pyj DNA POLYMERASE

(Bacillus virus
phi29) 		PF03175
(DNA_pol_B_2) 		4 LEU A 389
SER A 388
LEU A 263
PHE A 393
 None
 0.93A 3ln1B-2pyjA:
0.0		 3ln1B-2pyjA:
23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q1f CHONDROITINASE

(Bacteroides
thetaiotaomicron) 		PF02278
(Lyase_8)
PF09092
(Lyase_N)
PF09093
(Lyase_catalyt) 		4 LEU A 194
LEU A 353
ARG A 378
ILE A 382
 None
None
PO4  A2002 (-2.5A)
None
 0.88A 3ln1B-2q1fA:
undetectable		 3ln1B-2q1fA:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q9r PROTEIN OF UNKNOWN
FUNCTION

(Shewanella
baltica) 		PF04222
(DUF416) 		4 LEU A 164
SER A 163
ARG A  10
ILE A 168
 GOL  A 206 ( 4.9A)
GOL  A 206 (-2.9A)
None
None
 0.86A 3ln1B-2q9rA:
0.3		 3ln1B-2q9rA:
16.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qby CELL DIVISION
CONTROL PROTEIN 6
HOMOLOG 3

(Sulfolobus
solfataricus) 		PF09079
(Cdc6_C)
PF13401
(AAA_22) 		4 LEU B 113
SER B 111
LEU B 165
ILE B 136
 None
 0.95A 3ln1B-2qbyB:
undetectable		 3ln1B-2qbyB:
21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2v95 CORTICOSTEROID-BINDI
NG GLOBULIN

(Rattus
norvegicus) 		PF00079
(Serpin) 		4 LEU A 269
LEU A 354
ILE A 346
PHE A 348
 None
 0.93A 3ln1B-2v95A:
undetectable		 3ln1B-2v95A:
20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vsq SURFACTIN SYNTHETASE
SUBUNIT 3

(Bacillus
subtilis) 		PF00501
(AMP-binding)
PF00550
(PP-binding)
PF00668
(Condensation)
PF00975
(Thioesterase)
PF13193
(AMP-binding_C) 		4 LEU A1081
SER A1078
LEU A1215
ILE A1061
 None
 0.83A 3ln1B-2vsqA:
undetectable		 3ln1B-2vsqA:
18.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wb7 PT26-6P

(Thermococcus
sp. 26-2) 		no annotation 4 LEU A 218
ARG A 258
ILE A 232
PHE A 257
 None
 0.87A 3ln1B-2wb7A:
undetectable		 3ln1B-2wb7A:
19.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wya HYDROXYMETHYLGLUTARY
L-COA SYNTHASE,
MITOCHONDRIAL

(Homo sapiens) 		PF01154
(HMG_CoA_synt_N)
PF08540
(HMG_CoA_synt_C) 		4 SER A 272
LEU A 292
ILE A 277
PHE A 290
 None
 0.95A 3ln1B-2wyaA:
undetectable		 3ln1B-2wyaA:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xzi EXTRACELLULAR
SIALIDASE/NEURAMINID
ASE, PUTATIVE

(Aspergillus
fumigatus) 		PF13088
(BNR_2) 		5 LEU A 372
SER A 359
LEU A  90
ARG A  59
ILE A 390
 None
None
None
KDM  A 500 (-2.7A)
None
 1.26A 3ln1B-2xziA:
undetectable		 3ln1B-2xziA:
20.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y7d 3-KETO-5-AMINOHEXANO
ATE CLEAVAGE ENZYME

(Candidatus
Cloacimonas
acidaminovorans) 		PF05853
(BKACE) 		4 LEU A  47
LEU A  23
ARG A 226
ILE A  45
 None
None
ZN  A 301 ( 4.2A)
None
 0.80A 3ln1B-2y7dA:
undetectable		 3ln1B-2y7dA:
18.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yp2 HEMAGGLUTININ

(Influenza A
virus) 		PF00509
(Hemagglutinin) 		4 LEU A 177
LEU A  66
ARG A 150
ILE A 179
 None
 0.69A 3ln1B-2yp2A:
undetectable		 3ln1B-2yp2A:
22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ywq RIBOSOMAL SUBUNIT
INTERFACE PROTEIN

(Thermus
thermophilus) 		PF02482
(Ribosomal_S30AE) 		4 ARG A  68
LEU A  42
LEU A  25
ILE A  13
 None
 0.69A 3ln1B-2ywqA:
undetectable		 3ln1B-2ywqA:
10.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z1u HYDROGENASE
EXPRESSION/FORMATION
PROTEIN HYPE

(Desulfovibrio
vulgaris) 		PF00586
(AIRS)
PF02769
(AIRS_C) 		4 LEU A  24
ARG A 117
ILE A 123
PHE A  29
 None
 0.86A 3ln1B-2z1uA:
undetectable		 3ln1B-2z1uA:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zau SELENIDE, WATER
DIKINASE

(Aquifex
aeolicus) 		PF00586
(AIRS)
PF02769
(AIRS_C) 		4 LEU A 289
SER A 290
LEU A 166
ILE A 172
 None
 0.81A 3ln1B-2zauA:
undetectable		 3ln1B-2zauA:
20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ajf NON-STRUCTURAL
PROTEIN 3

(Rice hoja
blanca
tenuivirus) 		PF05310
(Tenui_NS3) 		4 LEU A  42
SER A  41
LEU A  83
ILE A  46
 None
 0.88A 3ln1B-3ajfA:
undetectable		 3ln1B-3ajfA:
12.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3amj ZINC PEPTIDASE
ACTIVE SUBUNIT

(Sphingomonas
sp. A1) 		no annotation 4 LEU C 374
SER C 375
ARG C 420
ILE C 296
 None
 0.95A 3ln1B-3amjC:
undetectable		 3ln1B-3amjC:
20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqs BACTERIAL REGULATORY
PROTEINS, TETR
FAMILY

(Corynebacterium
glutamicum) 		PF00440
(TetR_N) 		4 LEU A 175
SER A 174
ILE A 179
PHE A 128
 None
 0.70A 3ln1B-3aqsA:
undetectable		 3ln1B-3aqsA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3atb POTASSIUM
INWARDLY-RECTIFYING
CHANNEL, SUBFAMILY
J, MEMBER 6

(Mus musculus) 		PF01007
(IRK) 		4 LEU A 299
SER A 295
LEU A 243
ILE A 213
 None
 0.81A 3ln1B-3atbA:
undetectable		 3ln1B-3atbA:
17.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3auw POTASSIUM
INWARDLY-RECTIFYING
CHANNEL, SUBFAMILY
J, MEMBER 6

(Mus musculus) 		PF01007
(IRK) 		4 LEU B 299
SER B 295
LEU B 243
ILE B 213
 None
 0.95A 3ln1B-3auwB:
undetectable		 3ln1B-3auwB:
14.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b2d CD180 ANTIGEN

(Homo sapiens) 		PF00560
(LRR_1)
PF13855
(LRR_8) 		4 LEU A 281
LEU A 313
ILE A 263
PHE A 286
 None
 0.93A 3ln1B-3b2dA:
undetectable		 3ln1B-3b2dA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b2d CD180 ANTIGEN

(Homo sapiens) 		PF00560
(LRR_1)
PF13855
(LRR_8) 		4 LEU A 540
SER A 541
LEU A 574
ILE A 546
 None
 0.76A 3ln1B-3b2dA:
undetectable		 3ln1B-3b2dA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b2d CD180 ANTIGEN

(Homo sapiens) 		PF00560
(LRR_1)
PF13855
(LRR_8) 		4 LEU A 574
SER A 575
LEU A 589
ILE A 555
 None
 0.95A 3ln1B-3b2dA:
undetectable		 3ln1B-3b2dA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b89 16S RRNA METHYLASE

(Escherichia
coli) 		PF07091
(FmrO) 		4 ARG A 181
LEU A 176
LEU A 159
ILE A 172
 None
None
5GP  A 500 ( 4.3A)
None
 0.87A 3ln1B-3b89A:
undetectable		 3ln1B-3b89A:
17.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bln ACETYLTRANSFERASE
GNAT FAMILY

(Bacillus cereus) 		PF00583
(Acetyltransf_1) 		4 LEU A  68
LEU A  12
ILE A  70
PHE A  53
 MRD  A 146 ( 4.1A)
None
None
None
 0.90A 3ln1B-3blnA:
undetectable		 3ln1B-3blnA:
12.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bry TBUX

(Ralstonia
pickettii) 		PF03349
(Toluene_X) 		4 LEU A 165
LEU A 248
ILE A 202
PHE A 204
 None
None
C8E  A 502 (-4.0A)
None
 0.86A 3ln1B-3bryA:
undetectable		 3ln1B-3bryA:
21.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c4a PROBABLE TRYPTOPHAN
HYDROXYLASE VIOD

(Chromobacterium
violaceum) 		no annotation 4 LEU A 177
ARG A 180
ILE A 188
PHE A 179
 None
 0.73A 3ln1B-3c4aA:
undetectable		 3ln1B-3c4aA:
21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c7k GUANINE
NUCLEOTIDE-BINDING
PROTEIN G(O) SUBUNIT
ALPHA

(Mus musculus) 		PF00503
(G-alpha) 		4 LEU A 284
LEU A 269
ILE A 279
PHE A 275
 None
 0.92A 3ln1B-3c7kA:
undetectable		 3ln1B-3c7kA:
18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cn7 CARBOXYLESTERASE

(Pseudomonas
aeruginosa) 		PF02230
(Abhydrolase_2) 		5 LEU A  40
SER A  42
ARG A  44
ILE A  16
PHE A  45
 None
 1.48A 3ln1B-3cn7A:
undetectable		 3ln1B-3cn7A:
16.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cwv DNA GYRASE, B
SUBUNIT, TRUNCATED

(Myxococcus
xanthus) 		PF00204
(DNA_gyraseB) 		4 LEU A 107
SER A 108
ILE A 162
PHE A 163
 None
 0.87A 3ln1B-3cwvA:
undetectable		 3ln1B-3cwvA:
20.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dcy REGULATOR PROTEIN

(Homo sapiens) 		PF00300
(His_Phos_1) 		4 LEU A   6
LEU A 142
ILE A 240
PHE A   4
 None
 0.91A 3ln1B-3dcyA:
undetectable		 3ln1B-3dcyA:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dm0 MALTOSE-BINDING
PERIPLASMIC PROTEIN
FUSED WITH RACK1

(Arabidopsis
thaliana;
Escherichia
coli) 		PF00400
(WD40)
PF01547
(SBP_bac_1) 		4 SER A1122
ARG A1157
ILE A1167
PHE A1158
 None
 0.90A 3ln1B-3dm0A:
undetectable		 3ln1B-3dm0A:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3e6c CYCLIC
NUCLEOTIDE-BINDING
PROTEIN

(Desulfitobacterium
hafniense) 		PF00027
(cNMP_binding)
PF13545
(HTH_Crp_2) 		4 LEU C  83
SER C  82
ARG C  26
ILE C  22
 None
 0.92A 3ln1B-3e6cC:
undetectable		 3ln1B-3e6cC:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3e98 GAF DOMAIN OF
UNKNOWN FUNCTION

(Pseudomonas
aeruginosa) 		PF04340
(DUF484) 		4 LEU A  99
SER A  98
LEU A 183
ARG A 224
 None
 0.86A 3ln1B-3e98A:
undetectable		 3ln1B-3e98A:
18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3edv SPECTRIN BETA CHAIN,
BRAIN 1

(Homo sapiens) 		PF00435
(Spectrin) 		4 ARG A1980
LEU A1832
ARG A1915
PHE A1914
 None
 0.95A 3ln1B-3edvA:
undetectable		 3ln1B-3edvA:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3etu PROTEIN TRANSPORT
PROTEIN DSL1

(Saccharomyces
cerevisiae) 		PF11988
(Dsl1_N) 		5 ARG A 208
LEU A 233
SER A 138
LEU A 276
ILE A 224
 None
 1.48A 3ln1B-3etuA:
undetectable		 3ln1B-3etuA:
19.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fnr ARGINYL-TRNA
SYNTHETASE

(Campylobacter
jejuni) 		PF00750
(tRNA-synt_1d)
PF05746
(DALR_1) 		4 LEU A 351
SER A 350
ARG A 125
ILE A 121
 None
 0.91A 3ln1B-3fnrA:
undetectable		 3ln1B-3fnrA:
22.06